Table of Contents

Metformin is one of the most prescribed medications worldwide. This long-standing biguanide lowers blood sugar by reducing glucose production in the liver and improving how muscles and fat cells respond to insulin. It has been a first-line treatment for type 2 diabetes for decades and is also widely used for prediabetes, polycystic ovary syndrome (PCOS), obesity, and antipsychotic-related weight gain.

Metformin comes in immediate-release (IR) and extended-release (ER) forms, both of which are started at low doses and increased gradually to reduce stomach side effects.

This guide explains metformin dosing, how to start safely, when to take it, and how to reduce side effects.

Key Takeaways

  • Start low and titrate slowly. Begin with 500 mg once daily and increase gradually every one to two weeks to the target dose.
  • Take metformin with meals to reduce side effects.
  • Most adults take 1,500-2,550 mg/day, divided into one to three doses. Doses above 2,550 mg provide little additional benefit and may increase side effects.
  • In high-risk individuals with obesity, metformin can delay progression to type 2 diabetes and improve metabolic parameters in PCOS. Average weight loss with metformin is about 2-3 kg.
  • Discontinue metformin for PCOS after the first trimester and consult your clinician about its use in gestational diabetes.

Metformin dosing for type 2 diabetes

The table below summarises a typical titration plan for individuals starting metformin. Adjustments may vary. Always follow your doctor’s instructions.

1. Extended-release tablets

Formulation

Population Starting Dose Titration

Maximum Dose

Fortamet®

Adults

1000 mg once daily with evening meal Increase as needed

2500 mg/day

Glucophage® XR

Adults

500 mg once daily with evening meal Increase as needed

2000 mg/day

Glumetza®

Adults

500 mg once daily with evening meal Increase as needed

2000 mg/day

Metformin XR

Adults (when used alongside insulin)

500 mg once daily Increase by 500 mg weekly if needed

2500 mg/day

2. Extended-release oral suspension

Population

Starting Dose Titration

Maximum Dose

Adults and children 10-16 years

5 mL once daily with evening meal Increase by 5 mL weekly

20 mL/day

3. Oral solution

Use

Population Starting Dose Titration

Maximum Dose

Metformin alone

Adults

5 mL twice daily or 8.5 mL once daily with meals Increase as needed

25.5 mL/day

With insulin

Adults

5 mL once daily Increase as needed

25 mL/day

Metformin alone

Children 10-16 years

5 mL twice daily with meals

Increase as needed

20 mL/day

4. Immediate-release tablets

Use

Population Starting Dose Titration

Maximum Dose

Metformin alone

Adults 500 mg twice daily with meals or 850 mg once daily Increase as needed; may adjust to 500 or 850 mg 2-3 times daily

2550 mg/day

With insulin

Adults 500 mg once daily Increase by 500 mg weekly

2500 mg/day

Metformin alone

Children 10-16 years 500 mg twice daily with meals Increase as needed

2000 mg/day

SAVE 10% OFF your first order with coupon code: PGSAVE10

Metformin dosing for prediabetes

There is no official or standard dose of metformin specifically for prediabetes. Since metformin is FDA-approved for type 2 diabetes, doctors prescribe it off-label for prediabetes. That said, there is a commonly used dosing approach based on the Diabetes Prevention Program (DPP) study.

The DPP was a landmark trial that compared intensive lifestyle intervention, metformin, and placebo in nondiabetic adults with elevated blood sugar who were at risk of developing type 2 diabetes.

In the trial, participants took metformin 850 mg twice daily (1,700 mg per day total). That dose reduced the risk of developing type 2 diabetes by 31% over about 3 years. In a 10-year follow-up study, metformin reduced the risk by 18%.

A more recent meta-analysis compared different daily doses of metformin and found that 750 mg daily might be the most effective and best-tolerated dose for preventing diabetes in people with prediabetes

In practice, your metformin dose will depend on your individual health profile and how your body responds.

Metformin dosing for PCOS

According to the American Society for Reproductive Medicine (ASRM), metformin should be considered in adult women with PCOS and a BMI of 25 or more to improve:

    • weight and body measurements
    • insulin resistance
    • blood sugar levels
    • cholesterol levels

They recommend starting metformin at a low dose and increasing it by 500 mg every 1-2 weeks to reduce side effects. Extended-release forms may improve tolerability. The suggested maximum dose is 2,500 mg daily in adults and 2,000 mg in adolescents.

A UK-based guideline provides a similar approach:

Dose

Duration

500 mg once daily

Week 1 to 2

500 mg twice daily

Week 3 to 4

500 mg three times daily or 850 mg twice daily

Week 5 to 6

1,000 mg twice daily or 850 mg three times daily

Maintenance dose

Those who develop side effects can also follow a slower titration schedule:

Week

Dose

Week 1

250 mg once daily

Week 2

250 mg twice daily

Week 3

250 mg three times daily

Week 4

500 mg twice daily

Week 5

500 mg three times daily

Week 6

1,000 mg twice daily

Extended-release formulations can simplify dosing. The Children’s Hospital Colorado guidelines recommend starting at 500 mg once daily, then increasing every 1-2 weeks as tolerated:

    • 1,000 mg once daily,
    • then 1,500 mg once daily,
    • finally up to 2,000 mg once daily.

Duration of therapy and pregnancy

There is no fixed duration for metformin therapy in PCOS, and results will vary. It may take 6-12 months to improve excess hair growth and acanthosis. Some people notice clearer skin within about 3 months. Cycle regulation can take up to 6 months.

The Royal Berkshire leaflet advises reconsidering the drug if no benefits are seen after six months.

When considering pregnancy, the American Diabetes Association (ADA) 2025 Standards of Care in Diabetes update states that metformin used for PCOS should be stopped after the first trimester. Women planning pregnancy should discuss metformin use and potential alternatives with their healthcare provider.

Metformin dosing for weight loss

Although metformin is not approved as a weight-loss drug, clinicians sometimes prescribe it off-label for weight gain associated with antipsychotic medications or obesity.

The Cleveland Clinic notes that metformin doses of 1,500-2,000 mg/day lead to small reductions in weight and body mass index, with greater effects seen at doses above 1,500 mg/day.

The strongest evidence for weight loss with metformin in people without type 2 diabetes comes from the Diabetes Prevention Program (DPP) and its long-term follow-up, the Diabetes Prevention Program Outcomes Study (DPPOS).

In the DPP study, metformin users lost 2.1 kg (about 4.6 lbs) after about 3 years. In the DPPOS study, people on metformin maintained about 2.5 kg (5.51 lbs) of weight loss over 10 years. To add, about 30% of people on metformin lost more than 5% of their body weight in the first year. Those who responded early and stayed consistent were more likely to keep the weight off even after 15 years.

The largest trial designed primarily to measure weight loss in people without diabetes was the Biguanides and Prevention of the Risks in Obesity trial. In that study, the metformin group (1,700 mg/day) lost about 2 kg (4.41 lbs) after 12 months.

If larger weight loss is needed, discuss FDA-approved anti-obesity drugs with a clinician.

Metformin dosing for gestational diabetes

Metformin has been used off-label to treat gestational diabetes mellitus (GDM). However, the ADA’s 2025 update notes that hyperglycemia in pregnancy should not be treated with metformin as first-line therapy, as it can cross the placenta and reach the fetus, and they may not adequately control blood sugar levels.

Insulin remains the preferred medication for treating GDM and pre-existing type 2 diabetes in pregnancy.

Safety, side effects, and precautions

Metformin can cause side effects and may not be appropriate for everyone.

1. Gastrointestinal issues and vitamin B12

The most common side effects of metformin are nausea, bloating, flatulence, and diarrhea. These symptoms usually improve within a week or two and are less frequent with ER formulations. Starting with a low dose and taking metformin during meals helps.

Long-term use can decrease vitamin B12 absorption, so periodic testing and supplementation may be necessary.

2. Lactic acidosis

Lactic acidosis is a rare but serious complication. It is most likely to occur in people with severe kidney impairment, heart failure, liver disease, or heavy alcohol use. Symptoms include muscle pain, trouble breathing, and extreme fatigue.

To reduce risk, ensure kidney function is adequate before starting metformin and avoid excessive alcohol intake.

3. Renal dose adjustments

When using metformin, kidney function determines whether and how much you can take. Doctors use a lab value called eGFR (estimated glomerular filtration rate) to assess kidney function.

    • eGFR below 45 mL/min/1.73 m² Do not start metformin.
    • eGFR 45-60 mL/min/1.73 m² Limit total daily dose to 1,500 mg. (Up to 1,700 mg if using immediate-release metformin.)
    • eGFR 30-45 mL/min/1.73 m² and already taking metformin Reduce dose to a maximum of 1,000 mg per day.

The lower the kidney function, the lower the allowable dose, and below a certain level, metformin should not be started.

4. Other precautions

Other considerations include:

    • Surgery or imaging: Metformin may need to be temporarily stopped before procedures involving iodinated contrast dye. Discuss this with your healthcare team.
    • Pregnancy: Discontinue metformin for PCOS after the first trimester unless advised otherwise for GDM management.
    • Drug interactions: Some medications (e.g., cimetidine) can raise metformin levels. Inform your doctor of all medications and supplements.

Practical tips for taking metformin

Taking metformin the right way can improve results and reduce side effects. Here are practical tips to help you stay on track.

    • Take with meals: To reduce upset stomach, swallow tablets with a meal or right after eating.
    • Stay hydrated: Drink water throughout the day to support kidney clearance and reduce nausea.
    • Carry snacks when combining with other diabetes drugs: If you also take insulin or sulfonylureas, keep a carbohydrate snack nearby in case of low blood sugar.
    • Do not crush or chew extended-release tablets: Swallow whole to maintain the slow-release mechanism.
    • Use a pill organizer or reminder app: Consistency matters, and missing doses reduce effectiveness.
    • Ask about vitamin B12 testing: Check levels annually if you have been on metformin for several years.
    • Report persistent side effects: Severe or prolonged GI symptoms, muscle pain, or unusual tiredness warrant medical attention.

Bottom line

Metformin is a versatile and affordable medication used for type 2 diabetes, prediabetes, PCOS, and certain weight-related conditions. The optimal dosing schedule depends on the condition being treated, kidney function, and individual tolerance.

In general, start low, increase gradually, and take the tablets with food. Most adults end up on 1,500-2,000 mg/day, though some may require more or less. Ask your doctor whether metformin is right for you and what dose would best support your goals.

Frequently Asked Questions

There is no approved or established dose of metformin for anti-aging. Its use for longevity is still being studied, and it is not FDA-approved for this purpose. Any use outside of diabetes management should be discussed with a doctor.
Metformin is not approved to treat skin aging. Some early research suggests it may affect pathways linked to aging, but there is no strong clinical evidence showing it improves wrinkles or skin appearance.
There is no reliable evidence that metformin makes someone look younger. Research on aging focuses on cellular and metabolic effects, not cosmetic changes.
For people who are prescribed it, metformin is generally safe for daily use. It has been used long-term for type 2 diabetes with a well-established safety profile, though monitoring is still important.
Metformin lowers blood sugar by reducing glucose production in the liver and improving insulin sensitivity. Some people experience temporary stomach upset, such as nausea or diarrhea, when first starting.
Metformin is primarily prescribed to manage type 2 diabetes. It is also sometimes used for prediabetes and polycystic ovary syndrome to improve insulin resistance.
People with significantly reduced kidney function, certain liver conditions, or a history of lactic acidosis may need to avoid it. A healthcare provider should evaluate individual risks before starting therapy.
Metformin is usually taken with meals to reduce stomach side effects. Immediate-release (IR) metformin is usually taken twice daily, most commonly during breakfast and dinner. If prescribed three times daily, it’s taken with each main meal. Extended-release (ER) metformin is typically taken once daily in the evening.
Metformin does not typically cause kidney damage, but it should not be used in people with advanced kidney disease. Serious liver injury is rare, though caution is advised in patients with significant liver impairment.
If you stop metformin, blood sugar levels may rise again, especially in people with diabetes or prediabetes. Any decision to stop should be made with medical guidance.

Sources

Group, D. P. P. R. (2002). Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. New England Journal of Medicine, 346(6), 393–403. https://doi.org/10.1056/nejmoa012512

Knowler, W. C., Fowler, S. E., Hamman, R. F., Christophi, C. A., Hoffman, H. J., Brenneman, A. T., Brown-Friday, J. O., Goldberg, R., Venditti, E., & Nathan, D. M. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet, 374(9702), 1677–1686. https://doi.org/10.1016/s0140-6736(09)61457-4

Yi, X., Pan, Y., Peng, H., Ren, M., Jia, Q., & Wang, B. (2024). The optimal dose of metformin to control conversion to diabetes in patients with prediabetes: A meta-analysis. Journal of Diabetes and Its Complications, 38(10), 108846. https://doi.org/10.1016/j.jdiacomp.2024.108846

Metformin (oral route). (2026, February 1). Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/metformin-oral-route/description/drg-20067074

Metformin for PolycysticOvary Syndrome. (n.d.). Children’s Hospital Colorado. https://www.childrenscolorado.org/globalassets/departments/gynecology/informational-pdfs/options-for-managing-pcos-metformin.pdf

Use of Metformin for PCOS. (January, 2025). Royal Berkshire NHS. https://www.royalberkshire.nhs.uk/media/lpfcchj0/metformin-for-pcos_jan25.pdf

Committee, A. P. (2023). Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (2023). American Society for Reproductive Medicine. https://www.asrm.org/practice-guidance/practice-committee-documents/recommendations-from-the-2023-international-evidence-based-guideline-for-the-assessment-and-management-of-polycystic-ovary-syndrome/

Rodriguez, P., Pantalone, K., Griebeler. M., Burguera, B. (2026). Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?. Cleveland Clinic. https://www.ccjm.org/content/ccjom/90/9/545.full.pdf

Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., Brown, F. M., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., Everett, B. M., Garg, R., Laffel, L. M., Lal, R., Matfin, G., Pandya, N., Pekas, E. J., Peters, A. L., . . . ElSayed, N. A. (2025). 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2026. Diabetes Care, 49(Supplement_1), S321–S338. https://doi.org/10.2337/dc26-s015

Corcoran, C., & Jacobs, T. F. (2023, August 17). Metformin. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK518983/